Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Clay M. Anderson"'
Publikováno v:
Open Journal of Medical Psychology. :76-80
To assess relationships among physical health, mental health, spiritual experiences, religious practices, and perceived congregational support for individuals with cancer. Design: A cross-sectional analysis of 56 individuals from outpatient settings
Autor:
Jeffrey E. Lee, Wen-Jen Hwu, Rene Gonzalez, Agop Y. Bedikian, Omar Eton, Patrick Hwu, Ping Liu, Carl Plager, Kevin B. Kim, Marcella M. Johnson, Antonio C. Buzaid, Angela M. Frost, Robert S. Benjamin, Jeffrey E. Gershenwald, Victor G. Prieto, Paul F. Mansfield, Nicholas E. Papadopoulos, Clay M. Anderson, Merrick I. Ross, Gladys Alvarado, S. S. Legha
Publikováno v:
Melanoma Research. 19:42-49
The objective of this study was to compare the clinical benefit of biochemotherapy and interferon-alpha-2b (IFN) as adjuvant therapy. Biochemotherapy has higher response rates than other regimens in patients with metastatic melanoma. We conducted a r
Autor:
Clay M. Anderson, Chan Zeng, Karen Matijevich, Anna E. Barón, Martin D. McCarter, Rene Gonzalez, Steven J. O'Day, Nathan W. Pearlman, Karl D. Lewis, Thomas Amatruda, M. Becker, Susan Dollarhide, William A. Robinson
Publikováno v:
Journal of Clinical Oncology. 24:3157-3163
Purpose To determine the relapse-free survival, overall survival, and response rate of patients with stage III melanoma treated with neoadjuvant biochemotherapy in a multicenter setting. Patients and Methods Patients with pathologically proven stage
Autor:
Peter Gibbs, Jeffrey S. Weber, Rene Gonzalez, Anna E. Barón, Steven J. O'Day, Paul Russ, Karl D. Lewis, Clay M. Anderson, Chan Zeng, Jon M. Richards
Publikováno v:
Cancer Investigation. 23:303-308
Metastatic malignant melanoma remains a very difficult disease to treat. Previous phase II studies using biochemotherapy (combination of platinum-containing chemotherapy with IL-2 and IFNalpha) have shown response rates of about 50%. However, a site
Autor:
Clay M. Anderson, Antonio C. Buzaid
Publikováno v:
Current Oncology Reports. 2:322-328
Cutaneous melanoma is a significant and increasing clinical problem. Knowing accurately the prognosis in a given patient is critical for treatment decisions and for optimal patient education. In this article we discuss the most current information re
Autor:
Charles Koller, Stephen A. Wallner, Maher Albitar, Carlos E. Bueso-Ramos, Thomas E. Rosenzweig, Clay M. Anderson
Publikováno v:
Leukemia & Lymphoma. 32:385-390
We report one case of primary acute myelogenous leukemia (AML) and one case of refractory anemia with excess blasts in transformation (RAEB-T) each presenting concomitantly with multiple myeloma, an unusual finding. The twin diagnoses in each patient
Publikováno v:
Journal of Urology. 159:714-717
Purpose: We recently observed nonHodgkin's lymphoma and renal cell carcinoma occurring simultaneously in several patients. We determine whether the incidence of co-occurrence of the 2 malignancies is greater than expected based on the incidence of ea
Autor:
Evan M. Hersh, Thomas Amatruda, Jon M. Richards, Steven J. O'Day, Rene Gonzalez, Dave S.B. Hoon, Clay M. Anderson, Karl D. Lewis, Jeffrey S. Weber, He-Jing Wang, Peter D. Boasberg, Kazuo Koyanagi, Michael B. Atkins, Jose Lutzky, John A. Thompson
Purpose: Molecular biomarkers in blood are promising for assessment of tumor progression and treatment response. We hypothesized that serial monitoring of circulating tumor cells (CTC) with the use of multimarker quantitative real-time reverse transc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ba47e2b85fa7200325b3eb2222a497d
https://europepmc.org/articles/PMC2855775/
https://europepmc.org/articles/PMC2855775/
Autor:
Clay M. Anderson
Publikováno v:
Palliative Care ISBN: 9781607615897
Food and nutrition have social, spiritual, and cultural overlaying meanings beyond their importance to the biological integrity of human beings. The balance of benefit and burden with natural and artificial nutrition and hydration is complex and dyna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12b665f63b63f58b352de36853cbcc94
https://doi.org/10.1007/978-1-60761-590-3_3
https://doi.org/10.1007/978-1-60761-590-3_3
Autor:
Clay M. Anderson, Peter D. Boasberg, Rene Gonzalez, He-Jing Wang, Evan M. Hersh, Jeffrey S. Weber, Jose Lutzky, Steven J. O'Day, John A. Thompson, Thomas Amatruda, Michael B. Atkins
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(36)
PurposeBiochemotherapy improves responses in metastatic melanoma, but not overall survival, in randomized trials. We developed a maintenance biotherapy regimen after induction biochemotherapy in an attempt to improve durability of responses and overa